Shanghai Nianxing Industrial Co., Ltd
China
Product Name: N/A
Price:
Purity: 98.0%
Stocking Period: 10 Day
Contact: Yang

175799-93-6

175799-93-6 structure

Name: BODIPY FL prazosin
Chemical Name: BODIPY FL prazosin
CAS Number: 175799-93-6
Molecular Formula: C₂₈H₃₂BF₂N₇O₃
Molecular Weight: 563.41
Catalog: Signaling Pathways GPCR/G Protein Adrenergic Receptor
Create Date: 2022-11-15 20:16:06
Modify Date: 2024-01-16 12:24:44
BODIPY FL prazosin is a fluorescent α1-adrenergic antagonist with Ki values of 14.5, 43.3 nM for α1a-AR and α1b-AR, respectively. BODIPY FL prazosin also is a fluorescent ligand with the excitation and emission wavelengths are 485 and 535 nm, respectively. BODIPY FL prazosin can be used for study the differences in the subcellular localization of α1-adrenoceptor subtypes[1][2][3].

Name	BODIPY FL prazosin

Description	BODIPY FL prazosin is a fluorescent α1-adrenergic antagonist with Ki values of 14.5, 43.3 nM for α1a-AR and α1b-AR, respectively. BODIPY FL prazosin also is a fluorescent ligand with the excitation and emission wavelengths are 485 and 535 nm, respectively. BODIPY FL prazosin can be used for study the differences in the subcellular localization of α1-adrenoceptor subtypes[1][2][3].
Related Catalog	Signaling Pathways >> GPCR/G Protein >> Adrenergic Receptor Research Areas >> Metabolic Disease
Target	α1A-adrenergic receptor:14.5 nM (Ki) α1B-adrenergic receptor:43.3 nM (Ki)
In Vitro	BODIPY FL prazosin (10 nM; 30 min at room temperature in 100 μl; COS-7 cells) shows Affinity of various α1-AR ligands with Ki values of 14.5, 43.3 nM for α1a-AR and α1b-AR, respectively[1]. BODIPY FL prazosin (100 nM, 30 min) can be used as molecular probe for the Visualization of the non-adrenoceptor binding site of α1-adrenergic drugs in erythroleukemia cells[3].
References	[1]. Sugawara T, et al. Differences in the subcellular localization of alpha1-adrenoceptor subtypes can affect the subtype selectivity of drugs in a study with the fluorescent ligand BODIPY FL-prazosin. Life Sci. 2002 Mar 22;70(18):2113-24. [2]. Cerveny L, et al. Lack of interactions between breast cancer resistance protein (bcrp/abcg2) and selected antiepileptic agents. Epilepsia. 2006 Mar;47(3):461-8. [3]. Fuchs R, et al. α1-adrenergic drugs exhibit affinity to a thapsigargin-sensitive binding site and interfere with the intracellular Ca2+ homeostasis in human erythroleukemia cells. Exp Cell Res. 2011 Dec 10;317(20):2969-80.

Molecular Formula	C₂₈H₃₂BF₂N₇O₃
Molecular Weight	563.41

175799-93-6	2740620-18-0
1379771-95-5	216571-99-2
216571-88-9	133867-53-5
217190-17-5	217190-07-3
158757-79-0	217075-24-6
1158522-08-7	940364-43-2
2172188-64-4	134104-43-1
131615-57-1	6906-52-1
930439-75-1	1018584-77-4
2137619-19-1	1375289-11-4